ResearcherNanchang UniversityActive in the last 2 years

Yeqing Zou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5147529884. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

VEZT promotes pancreatic cancer progression by stabilizing SLC25A24 and preserving mitochondrial function. Last author DOI 10.3389/fimmu.2026.1900975 ↗
ESCO1 stabilizes NUFIP2 through acetylation-ubiquitination crosstalk to promote pancreatic cancer progression. Last author DOI 10.3389/fimmu.2026.1929713 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Letian Chen · 1 shared paper, 2026 · strength 0.36
- Paper VEZT promotes pancreatic cancer progression by stabilizing SLC25A24 and preserving mitochondrial function. DOI 10.3389/fimmu.2026.1900975 ↗
Letian Chen · 1 shared paper, 2026 · strength 0.32
- Paper ESCO1 stabilizes NUFIP2 through acetylation-ubiquitination crosstalk to promote pancreatic cancer progression. DOI 10.3389/fimmu.2026.1929713 ↗
Xiaowei Fu · 1 shared paper, 2026 · strength 0.32
- Paper ESCO1 stabilizes NUFIP2 through acetylation-ubiquitination crosstalk to promote pancreatic cancer progression. DOI 10.3389/fimmu.2026.1929713 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.